286 related articles for article (PubMed ID: 11563046)
1. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings.
Ravi G; Lee K; Ji X; Kim HS; Soltysiak KA; Marquez VE; Jacobson KA
Bioorg Med Chem Lett; 2001 Sep; 11(17):2295-300. PubMed ID: 11527718
[TBL] [Abstract][Full Text] [Related]
3. Structurally related nucleotides as selective agonists and antagonists at P2Y1 receptors.
Jacobson KA; Moro S; Hoffmann C; Kim YC; Kim HS; Ravi RG; Harden TK; Boyer JL
Farmaco; 2001; 56(1-2):71-5. PubMed ID: 11347970
[TBL] [Abstract][Full Text] [Related]
4. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
5. Agonists and antagonists for P2 receptors.
Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.
Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 2000 Mar; 43(5):829-42. PubMed ID: 10715151
[TBL] [Abstract][Full Text] [Related]
7. Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor.
Houston D; Costanzi S; Jacobson KA; Harden TK
Comb Chem High Throughput Screen; 2008 Jul; 11(6):410-9. PubMed ID: 18673269
[TBL] [Abstract][Full Text] [Related]
8. Action of nucleosides and nucleotides at 7 transmembrane-spanning receptors.
Jacobson KA; Costanzi S; Kim SK; Roh E; Joshi BV; Tchilibon S; Duong HT; Gao ZG
Nucleosides Nucleotides Nucleic Acids; 2006; 25(12):1425-36. PubMed ID: 17067963
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
[TBL] [Abstract][Full Text] [Related]
10. Nomenclature and classification of purinoceptors.
Fredholm BB; Abbracchio MP; Burnstock G; Daly JW; Harden TK; Jacobson KA; Leff P; Williams M
Pharmacol Rev; 1994 Jun; 46(2):143-56. PubMed ID: 7938164
[No Abstract] [Full Text] [Related]
11. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites.
Moro S; Guo D; Camaioni E; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 1998 Apr; 41(9):1456-66. PubMed ID: 9554879
[TBL] [Abstract][Full Text] [Related]
12. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.
Morrone FB; Jacques-Silva MC; Horn AP; Bernardi A; Schwartsmann G; Rodnight R; Lenz G
J Neurooncol; 2003 Sep; 64(3):211-8. PubMed ID: 14558596
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA
J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide coronary vasodilation in guinea pig hearts.
Gorman MW; Ogimoto K; Savage MV; Jacobson KA; Feigl EO
Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1040-7. PubMed ID: 12763753
[TBL] [Abstract][Full Text] [Related]
15. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.
Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK
Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804
[TBL] [Abstract][Full Text] [Related]
16. Adenosine receptor ligands: where are we, and where are we going?
Tuccinardi T; Martinelli A
Curr Top Med Chem; 2010; 10(10):941. PubMed ID: 20681944
[No Abstract] [Full Text] [Related]
17. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
Jacobson KA; IJzerman AP; Müller CE
Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
[TBL] [Abstract][Full Text] [Related]
18. Purine and pyrimidine receptors.
Burnstock G
Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
[TBL] [Abstract][Full Text] [Related]
19. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA
J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
